TRxADE Health, Inc. Announces Business Combination with Scienture, Inc., in a Transaction Valued at $103 Million
Written by Emily J. Thompson, Senior Investment Analyst
Updated: Jul 26 2024
0mins
Source: Newsfilter
Business Combination Announcement: Scienture, Inc. has completed an all-stock business combination with TRxADE Health Inc., valued at $103 million, resulting in a new company named "Scienture Holdings, Inc." that will focus on innovative specialty pharmaceutical products.
Future Plans and Structure: The combined entity aims to enhance patient care through unique product solutions, with current Scienture stockholders expected to own approximately 82.99% of the equity interests post-combination, while TRxADE's leadership will continue to guide the new company.
About the author
Emily J. Thompson
Emily J. Thompson, a Chartered Financial Analyst (CFA) with 12 years in investment research, graduated with honors from the Wharton School. Specializing in industrial and technology stocks, she provides in-depth analysis for Intellectia’s earnings and market brief reports.
